MIR155, microRNA 155, 406947

N. diseases: 584; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036572
Disease: Seizures
Seizures
0.050 Biomarker phenotype BEFREE Results suggest the role of miR-155 in regulating post-ischaemic seizures via PICs-GABA mechanisms. 31144434 2019
CUI: C0036572
Disease: Seizures
Seizures
0.050 Biomarker phenotype BEFREE The mice in the KA group developing acute seizure were further subjected to intracerebroventricular injection (i.c.v.) of antagomir negative control (NC) or miR-155 antagomir. 30928987 2019
CUI: C0036572
Disease: Seizures
Seizures
0.050 AlteredExpression phenotype BEFREE The expression of TNF-α reached peak levels in the acute phase (2h post-SE) of seizure and then gradually decreased; however, it rose again in the chronic phase (60 days post-SE). miR-155 expression started to increase 2 h post-SE, reached peak levels in the latent phase (7 days post-SE) of seizure and then gradually decreased. 30006293 2018
CUI: C0036572
Disease: Seizures
Seizures
0.050 AlteredExpression phenotype BEFREE In addition, rno-miR-155-5p as well as rat Sestrin-3 mRNA and protein expression were partly dependent on oxidative stress induced by H<sub>2</sub>O<sub>2</sub> in PC12 cells<sub>.</sub> Taken together, our data suggest that rno-miR-155-5p is a potent post-transcriptional regulator of rat Sestrin-3 and it may be one of the molecular links between brain damage and increased risk for seizures during damage by oxidative stress. 29191771 2018
CUI: C0036572
Disease: Seizures
Seizures
0.050 Biomarker phenotype BEFREE RT‑qPCR analysis indicated that miR‑155 levels in patients who experienced seizures increased 2.45‑fold compared with patient who did not experience seizures, indicating miR‑155 may be a potential biomarker for the occurrence of seizures. 29115566 2018